World's Best Scientists 2026 revealed!
VIEW LIST
Tibor Keler

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 61 3234 2981 1510 1382 214 13449

Tibor Keler publications per year

The chart shows the history of publications by Tibor Keler between 1984 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Tibor Keler published across 42 years, from 1984 to 2025, averaging 7.6 papers a year. Output peaked at 61 publications in 2023. 51 of the 319 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1984 to 2025. Vertical axis: number of publications, 0 to 61. Peak 61 publications in 2023. 1984: 1 publication 1985: 0 publications 1986: 1 publication 1987: 1 publication 1988: 1 publication 1989: 1 publication 1990: 2 publications 1991: 0 publications 1992: 2 publications 1993: 2 publications 1994: 0 publications 1995: 1 publication 1996: 2 publications 1997: 6 publications 1998: 2 publications 1999: 3 publications 2000: 5 publications 2001: 5 publications 2002: 0 publications 2003: 3 publications 2004: 4 publications 2005: 5 publications 2006: 3 publications 2007: 5 publications 2008: 3 publications 2009: 4 publications 2010: 5 publications 2011: 6 publications 2012: 8 publications 2013: 11 publications 2014: 11 publications 2015: 12 publications 2016: 21 publications 2017: 14 publications 2018: 11 publications 2019: 10 publications 2020: 15 publications 2021: 7 publications 2022: 14 publications 2023: 61 publications 2024: 5 publications 2025: 46 publications
1984 2025

319 publications in total across all disciplines

View publications per year as a table
Tibor Keler: publications per year, 1984 to 2025
Year Publications
1984 1
1985 0
1986 1
1987 1
1988 1
1989 1
1990 2
1991 0
1992 2
1993 2
1994 0
1995 1
1996 2
1997 6
1998 2
1999 3
2000 5
2001 5
2002 0
2003 3
2004 4
2005 5
2006 3
2007 5
2008 3
2009 4
2010 5
2011 6
2012 8
2013 11
2014 11
2015 12
2016 21
2017 14
2018 11
2019 10
2020 15
2021 7
2022 14
2023 61
2024 5
2025 46
Total 319
Download as CSV

Tibor Keler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tibor Keler sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 212–221 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 214 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158 214
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Tibor Keler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tibor Keler sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 60–61 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197 61
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Tibor Keler is affiliated with Bristol-Myers Squibb in the United States. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. Keler's work is especially concentrated on oncology and immunology as subfields, with additional involvement in radiology, nuclear medicine, imaging, pulmonary and respiratory medicine, and molecular biology.

Throughout Keler's career, their research topics have included:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T Cell Therapy Research
  • Monoclonal and Polyclonal Antibodies Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Mast Cells and Histamine

Keler has published in various scientific venues, with frequent publications appearing in:

  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Allergy
  • Journal of Clinical Oncology
  • Clinical Cancer Research

Notable recent papers include:

  • "Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial," published in Clinical Cancer Research (2020)
  • "Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s," published in Nature Communications (2020)
  • "Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets," published in Nature Cancer (2020)
  • "Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies," published in Blood Advances (2020)
  • "Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study," published in Allergy (2022)

Frequent coauthors collaborating with Keler include:

  • Michael Yellin
  • Laura Vitale
  • Diego Alvarado
  • Lawrence J. Thomas
  • Henry C. Marsh

Best Publications

  • Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

    Marina Caskey;Florian Klein;Julio C. C. Lorenzi;Michael S. Seaman

  • Autoimmunity in a Phase I Trial of a Fully Human Anti-Cytotoxic T-Lymphocyte Antigen-4 Monoclonal Antibody With Multiple Melanoma Peptides and Montanide ISA 51 for Patients With Resected Stages III and IV Melanoma

    Kristin Sanderson;Ronald Scotland;Peter Lee;Dongxin Liu

  • HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

    Johannes F. Scheid;Johannes F. Scheid;Joshua A. Horwitz;Yotam Bar-On;Edward F. Kreider

  • Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

    Marina Caskey;Till Schoofs;Henning Gruell;Allison Settler

  • A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

    James Schuster;Rose K. Lai;Rose K. Lai;Lawrence D. Recht;David A. Reardon;David A. Reardon

  • Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

    Madhav V. Dhodapkar;Mario Sznol;Biwei Zhao;Ding Wang

  • Phase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma

    Stephen M. Ansell;Steven M. Horwitz;Andreas Engert;Khuda Dad Khan

  • High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization.

    Marcela Alcántara-Hernández;Rebecca Leylek;Lisa E. Wagar;Edgar G. Engleman

  • Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells.

    Bithi Chatterjee;Bithi Chatterjee;Anna Smed-Sörensen;Anna Smed-Sörensen;Lillian Cohn;Cécile Chalouni

  • Mannose receptor-targeted vaccines

    Tibor Keler;Venky Ramakrishna;Michael W Fanger

  • Human monoclonal antibodies to her2/neu

    Tibor Keler;Yashwant Deo

  • Circulating precursors of human CD1c+ and CD141+ dendritic cells

    Gaëlle Breton;Jaeyop Lee;Yu Jerry Zhou;Joseph J. Schreiber

  • Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation

    Lillian Cohn;Bithi Chatterjee;Filipp Esselborn;Anna Smed-Sörensen;Anna Smed-Sörensen

  • Dendritic cell‐targeted protein vaccines: a novel approach to induce T‐cell immunity

    C. Trumpfheller;M. P. Longhi;M. Caskey;J. Idoyaga

  • Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques

    Tibor Keler;Ed Halk;Laura Vitale;Tom O’Neill

  • Antigenic targeting of the human mannose receptor induces tumor immunity.

    Li-Zhen He;Andrea Crocker;Janine Lee;Jose Mendoza-Ramirez

  • Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates

    Kavita Tewari;Barbara J. Flynn;Silvia B. Boscardin;Kathrin Kastenmueller

  • Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti–human DEC205 monoclonal antibody

    Cheolho Cheong;Jae Hoon Choi;Laura Vitale;Li Zhen He

  • Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules

    Venky Ramakrishna;John F. Treml;Laura Vitale;John E. Connolly

  • Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients

    Michael A. Morse;Robert Chapman;John Powderly;Kimberly Blackwell

  • Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates

    Barbara J. Flynn;Kathrin Kastenmüller;Ulrike Wille-Reece;Georgia D. Tomaras

Frequent Co-Authors

Nina Bhardwaj
Nina Bhardwaj Icahn School of Medicine at Mount Sinai
Thomas P. Davis
Thomas P. Davis University of Arizona
Paul K. Wallace
Paul K. Wallace Roswell Park Cancer Institute
Marina Caskey
Marina Caskey Rockefeller University
David A. Reardon
David A. Reardon Harvard University
John H. Sampson
John H. Sampson Duke University
Jan G. J. van de Winkel
Jan G. J. van de Winkel Genmab (United States)
Ralph M. Steinman
Ralph M. Steinman Rockefeller University
Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Stephen M. Ansell
Stephen M. Ansell Mayo Clinic

External Links

Personal website of Tibor Keler

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields through online education can open diverse career opportunities. Many students transition into immunology by first gaining clinical experience via accelerated nursing pathways. For example, accelerated NP programs provide a fast-track route to becoming a nurse practitioner, combining advanced clinical skills with patient care knowledge.

If you are new to nursing, online options like online accelerated nursing programs for non nurses offer accessible entry points. These programs are designed to build foundational nursing expertise quickly while allowing flexibility for career changers.

For those aiming to start at the undergraduate level, understanding which universities offer the easiest ABSN to get into can help reduce barriers when pursuing a Bachelor of Science in Nursing. Such programs often provide a streamlined curriculum tailored to students who want a fast educational path.

Similarly, exploring which LPN programs are easiest to get into can assist aspiring Licensed Practical Nurses in finding programs with simpler admission criteria, serving as a stepping stone toward advanced immunology-related roles in healthcare.

Best Scientists Citing Tibor Keler

Michel C. Nussenzweig

Michel C. Nussenzweig

Rockefeller University

Publications: 76

Jan G. J. van de Winkel

Jan G. J. van de Winkel

Genmab (United States)

Publications: 50

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 40

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 37

Dan H. Barouch

Dan H. Barouch

Harvard Medical School

Publications: 34

John R. Mascola

John R. Mascola

ModeX Therapeutics

Publications: 33

Sandra Zurawski

Sandra Zurawski

Baylor University

Publications: 29

David C. Montefiori

David C. Montefiori

Duke University

Publications: 28

Jose R. Conejo-Garcia

Jose R. Conejo-Garcia

Duke University

Publications: 27

Gerard Zurawski

Gerard Zurawski

Baylor University

Publications: 27

Irina Caminschi

Irina Caminschi

Monash University

Publications: 27

Dennis R. Burton

Dennis R. Burton

Scripps Research Institute

Publications: 26

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 25

Paul W. H. I. Parren

Paul W. H. I. Parren

Leiden University Medical Center

Publications: 24

Marina Caskey

Marina Caskey

Rockefeller University

Publications: 24

Jacques Banchereau

Jacques Banchereau

Immunai

Publications: 23

Trending Scientists

Andreas Bund

Andreas Bund

Ilmenau University of Technology

Michael J. Uren

Michael J. Uren

University of Bristol

Julien Ryckaert

Julien Ryckaert

Imec

Alexander M. Wyglinski

Alexander M. Wyglinski

Worcester Polytechnic Institute

David J. Perreault

David J. Perreault

MIT

Asgeir J. Sørensen

Asgeir J. Sørensen

Norwegian University of Science and Technology

Cort W. Rudolph

Cort W. Rudolph

Wayne State University

Robert A. Giacalone

Robert A. Giacalone

Texas State University

Luis E. Ibáñez

Luis E. Ibáñez

Autonomous University of Madrid

Juan M. Rodríguez

Juan M. Rodríguez

Complutense University of Madrid

Howard R. Gordon

Howard R. Gordon

University of Miami

Germán Poveda

Germán Poveda

National University of Colombia

Charles Gerday

Charles Gerday

University of Liège

Margaret Eisenhart

Margaret Eisenhart

University of Colorado Boulder

Lionel Tarassenko

Lionel Tarassenko

University of Oxford

Stephen B. Johnson

Stephen B. Johnson

Columbia University

Related Immunology Rankings & Guides

2027 Best Direct-Entry NP Programs for Non-Nurses

2027 Best Direct-Entry NP Programs for Non-Nurses
2027 Best LPN Programs in South Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in South Carolina – Accredited Online LPN Programs
2027 Best ADN Nursing Programs in Texas: Online & Campus

2027 Best ADN Nursing Programs in Texas: Online & Campus
2027 Best LVN Programs in California – Accredited Online LVN Programs

2027 Best LVN Programs in California – Accredited Online LVN Programs
2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference

2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference
2027 Best 12-Month FNP Programs (Online & Campus)

2027 Best 12-Month FNP Programs (Online & Campus)
2027 Best LVN Programs in Texas – Accredited Online LPN Programs

2027 Best LVN Programs in Texas – Accredited Online LPN Programs
2027 Best Direct-Entry Nurse Practitioner Programs

2027 Best Direct-Entry Nurse Practitioner Programs
2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs
2027 Best Master’s in Medical Science Programs

2027 Best Master’s in Medical Science Programs
2027 Best LPN Programs in Georgia – Accredited Online LPN Programs

2027 Best LPN Programs in Georgia – Accredited Online LPN Programs
2027 Best LPN Programs in New York – Accredited Online LPN Programs

2027 Best LPN Programs in New York – Accredited Online LPN Programs
2027 Best ABSN Programs - Accelerated BSN Programs in Georgia: Online & Campus

2027 Best ABSN Programs - Accelerated BSN Programs in Georgia: Online & Campus
2027 Best MRI Technician Programs

2027 Best MRI Technician Programs
2027 Best LPN Programs in Florida – Accredited Online LPN Programs

2027 Best LPN Programs in Florida – Accredited Online LPN Programs
2027 Best Accelerated BSN to PhD Online Bridge Programs

2027 Best Accelerated BSN to PhD Online Bridge Programs
2027 Best CNA to RN Degree Online Bridge Programs

2027 Best CNA to RN Degree Online Bridge Programs
2027 Best Accelerated Nurse Practitioner NP Online Programs

2027 Best Accelerated Nurse Practitioner NP Online Programs
2027 Best Accelerated LVN to RN Online Bridge Programs

2027 Best Accelerated LVN to RN Online Bridge Programs
2027 Best Medical Transcription Courses Online

2027 Best Medical Transcription Courses Online
2027 Best Accelerated Healthcare Administration Degree Programs Online

2027 Best Accelerated Healthcare Administration Degree Programs Online

Recently Published Articles

2027 Cheapest Accredited Online Clinical Psychology Degree Programs: Tuition, Fees, and Financial Aid

2027 Cheapest Accredited Online Clinical Psychology Degree Programs: Tuition, Fees, and Financial Aid
2027 Which Curriculum & Instruction Specializations Have the Best Job Outlook?

2027 Which Curriculum & Instruction Specializations Have the Best Job Outlook?
2027 Best Online Data Analytics Degree Programs

2027 Best Online Data Analytics Degree Programs
2027 How to Pay for an Information Technology Master's Degree with Financial Aid

2027 How to Pay for an Information Technology Master's Degree with Financial Aid
2027 Online Forensic Psychology Degree Programs Costs: Tuition & Fees

2027 Online Forensic Psychology Degree Programs Costs: Tuition & Fees
2027 Is a 2-Year Applied Science Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs

2027 Is a 2-Year Applied Science Degree Worth It: Accelerated Bachelor's ROI & Time Trade-Offs
2027 Best Accredited Online Addiction Counseling Degree Programs: Compare Tuition, Admissions, and Career Outcomes

2027 Best Accredited Online Addiction Counseling Degree Programs: Compare Tuition, Admissions, and Career Outcomes
2027 Competency-Based Online Care Coordination Master's Degrees

2027 Competency-Based Online Care Coordination Master's Degrees
2027 Most Affordable Online Associate Degrees

2027 Most Affordable Online Associate Degrees
2027 What Prerequisites Do You Need for a Public Administration Master's Degree? Entry Requirements, Credits & Eligibility Rules

2027 What Prerequisites Do You Need for a Public Administration Master's Degree? Entry Requirements, Credits & Eligibility Rules
2027 Can a Child Development Degree Lead to Remote Jobs?

2027 Can a Child Development Degree Lead to Remote Jobs?
2027 What Can You Do with a Sports Management Master's Degree? Careers, Salaries & Growth

2027 What Can You Do with a Sports Management Master's Degree? Careers, Salaries & Growth
2027 Engineering Degree vs. Certificate: Which Should You Choose?

2027 Engineering Degree vs. Certificate: Which Should You Choose?
2027 Can Nurse Practitioners Prescribe Medication?

2027 Can Nurse Practitioners Prescribe Medication?
2027 Most Flexible Careers You Can Pursue With a Science Degree: Remote, Hybrid, and Freelance Paths

2027 Most Flexible Careers You Can Pursue With a Science Degree: Remote, Hybrid, and Freelance Paths
2027 Average Cyber Security Salary by State

2027 Average Cyber Security Salary by State
2027 Fastest-Growing Careers for Psychopharmacology Degree Graduates

2027 Fastest-Growing Careers for Psychopharmacology Degree Graduates
2027 Is Walden University's Online BSN to MSN - Adult Gerontology Acute Care Nurse Practitioner Worth It? What Students Should Know

2027 Is Walden University's Online BSN to MSN - Adult Gerontology Acute Care Nurse Practitioner Worth It? What Students Should Know
2027 Military-Friendly Online Criminal Justice Degree Programs: Benefits, Accreditation, and Career Outcomes

2027 Military-Friendly Online Criminal Justice Degree Programs: Benefits, Accreditation, and Career Outcomes
2027 How to Become a Substance Abuse Counselor in Oklahoma

2027 How to Become a Substance Abuse Counselor in Oklahoma
2027 How to Become a High School Math Teacher in Washington

2027 How to Become a High School Math Teacher in Washington